Income Statement - Bicara Therapeutics Inc. (BCAX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 0.06 | 0.02 | 0.01 | |
| Gross profit | -0.06 | -0.02 | -0.01 | |
| Total operating expenses | 155.60 | 82.39 | 39.89 | 37.66 |
| Operating income | -155.60 | -82.39 | -39.89 | -37.66 |
| Non-operating income (net) | 17.87 | 14.58 | -12.09 | -0.19 |
| Income before tax | -137.73 | -67.81 | -51.98 | -37.84 |
| Income tax expense | 0.22 | 0.19 | 0.01 | 0.00 |
| Net income | -137.95 | -68.00 | -51.99 | -37.85 |
Show Quarterly Income Statement
Income Statement - Bicara Therapeutics Inc. (BCAX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Cost of revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | ||||||
| Gross profit | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | ||||||
| Total operating expenses | 60.24 | 41.12 | 40.68 | 32.02 | 41.79 | 26.64 | 20.63 | 19.75 | 15.37 | 13.69 | 9.53 | 8.34 | 8.34 |
| Operating income | -60.24 | -41.12 | -40.68 | -32.02 | -41.79 | -26.64 | -20.63 | -19.75 | -15.37 | -13.69 | -9.53 | -8.34 | -8.34 |
| Non-operating income (net) | 4.08 | 3.79 | 4.39 | 4.68 | 5.01 | 5.87 | 3.15 | 2.70 | 2.87 | 1.25 | -13.32 | -0.01 | -0.01 |
| Income before tax | -56.16 | -37.33 | -36.29 | -27.34 | -36.77 | -20.77 | -17.48 | -17.05 | -12.51 | -12.44 | -22.85 | -8.35 | -8.35 |
| Income tax expense | -0.05 | 0.05 | 0.04 | 0.05 | 0.07 | 0.19 | 0.00 | 0.00 | 0.01 | ||||
| Net income | -56.21 | -37.39 | -36.33 | -27.39 | -36.85 | -20.96 | -17.48 | -17.05 | -12.51 | -12.44 | -22.85 | -8.35 | -8.35 |